These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 11391452)
1. Effects of in-center daily hemodialysis upon mineral metabolism and bone disease in end-stage renal disease patients. Lugon JR; André MB; Duarte ME; Rembold SM; Cruz E Sao Paulo Med J; 2001 May; 119(3):105-9. PubMed ID: 11391452 [TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of an in-center daily hemodialysis program: results of two years of treatment. André MB; Rembold SM; Pereira CM; Lugon JR Am J Nephrol; 2002; 22(5-6):473-9. PubMed ID: 12381946 [TBL] [Abstract][Full Text] [Related]
3. Controlled study of renal osteodystrophy in patients undergoing dialysis. Improved response to continuous ambulatory peritoneal dialysis compared with hemodialysis. Shusterman NH; Wasserstein AG; Morrison G; Audet P; Fallon MD; Kaplan F Am J Med; 1987 Jun; 82(6):1148-56. PubMed ID: 3605132 [TBL] [Abstract][Full Text] [Related]
4. The spectrum of bone disease in 200 chronic hemodialysis patients: a correlation between clinical, biochemical and histological findings. Duarte ME; Peixoto AL; Pacheco AS; Peixoto AV; Rodriguez RD; Lugon JR; Cruz EA Sao Paulo Med J; 1998; 116(5):1790-7. PubMed ID: 10030103 [TBL] [Abstract][Full Text] [Related]
5. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function. Wang M; Obi Y; Streja E; Rhee CM; Lau WL; Chen J; Hao C; Hamano T; Kovesdy CP; Kalantar-Zadeh K Clin J Am Soc Nephrol; 2017 Jul; 12(7):1118-1127. PubMed ID: 28487345 [TBL] [Abstract][Full Text] [Related]
6. Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis. Avila-Díaz M; Matos M; García-López E; Prado MD; Castro-Vázquez F; Ventura MD; González E; Amato D; Paniagua R Perit Dial Int; 2006; 26(1):78-84. PubMed ID: 16538879 [TBL] [Abstract][Full Text] [Related]
7. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]
8. Assessment of renal osteodystrophy in hemodialysis patients. DeVita MV; Rasenas LL; Bansal M; Gleim GW; Zabetakis PM; Gardenswartz MH; Michelis MF Medicine (Baltimore); 1992 Sep; 71(5):284-90. PubMed ID: 1522804 [TBL] [Abstract][Full Text] [Related]
9. Renal osteodystrophy in Ramathibodi Hospital: histomorphometry and clinical correlation. Changsirikulchai S; Domrongkitchaiporn S; Sirikulchayanonta V; Ongphiphadhanakul B; Kunkitti N; Stitchantrakul W; Radienahamed P J Med Assoc Thai; 2000 Oct; 83(10):1223-32. PubMed ID: 11143489 [TBL] [Abstract][Full Text] [Related]
10. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Elsharkawy MM; Youssef AM; Zayoon MY Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745 [TBL] [Abstract][Full Text] [Related]
11. Calcium mass balances during standard bicarbonate hemodialysis and long-hour slow-flow bicarbonate hemodialysis. Basile C; Libutti P; Di Turo AL; Tundo S; Maselli P; Casucci F; Losurdo N; Teutonico A; Vernaglione L; Lomonte C J Nephrol; 2011; 24(6):742-8. PubMed ID: 21360470 [TBL] [Abstract][Full Text] [Related]
12. Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital. Mathias R; Salusky I; Harman W; Paredes A; Emans J; Segre G; Goodman W J Am Soc Nephrol; 1993 Jun; 3(12):1938-46. PubMed ID: 8338926 [TBL] [Abstract][Full Text] [Related]
13. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings. Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018 [TBL] [Abstract][Full Text] [Related]
14. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels. Gal-Moscovici A; Popovtzer MM Clin Nephrol; 2005 Apr; 63(4):284-9. PubMed ID: 15847255 [TBL] [Abstract][Full Text] [Related]
15. The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. Noordzij M; Korevaar JC; Boeschoten EW; Dekker FW; Bos WJ; Krediet RT; Am J Kidney Dis; 2005 Nov; 46(5):925-32. PubMed ID: 16253734 [TBL] [Abstract][Full Text] [Related]
16. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients. Navarro JF; Mora C; Macia M; Garcia J Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859 [TBL] [Abstract][Full Text] [Related]
17. Consequences of the implementation of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease in a population of patients on chronic hemodialysis. Arenas MD; Alvarez-Ude F; Torregrosa V; Gil MT; Carretón MA; Moledous A; Nuñez C; Devesa R; Albiach B J Nephrol; 2007; 20(4):453-61. PubMed ID: 17879212 [TBL] [Abstract][Full Text] [Related]
18. Calcium, phosphate, and PTH levels in the hemodialysis population: a multicenter study. Gallieni M; Cucciniello E; D'Amaro E; Fatuzzo P; Gaggiotti A; Maringhini S; Rotolo U; Brancaccio D; J Nephrol; 2002; 15(2):165-70. PubMed ID: 12018633 [TBL] [Abstract][Full Text] [Related]
19. Effects of high dialysate calcium concentration on bone remodelling, serum biochemistry, and parathyroid hormone in patients with renal osteodystrophy. Drüeke T; Bordier PJ; Man NK; Jungers P; Marie P Kidney Int; 1977 Apr; 11(4):267-74. PubMed ID: 857076 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for renal osteodystrophy: a multivariant analysis. Pei Y; Hercz G; Greenwood C; Segre G; Manuel A; Saiphoo C; Fenton S; Sherrard D J Bone Miner Res; 1995 Jan; 10(1):149-56. PubMed ID: 7747622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]